Your browser doesn't support javascript.
loading
"High-risk" host cell proteins (HCPs): A multi-company collaborative view.
Jones, Marisa; Palackal, Nisha; Wang, Fengqiang; Gaza-Bulseco, Georgeen; Hurkmans, Karen; Zhao, Yiwei; Chitikila, Carmelata; Clavier, Severine; Liu, Suli; Menesale, Emily; Schonenbach, Nicole S; Sharma, Satish; Valax, Pascal; Waerner, Thomas; Zhang, Lei; Connolly, Trish.
Afiliação
  • Jones M; GlaxoSmithKline, CMC Analytical, Structure & Function Characterization, Collegeville, Pennsylvania, USA.
  • Palackal N; Regeneron Pharmaceuticals Inc., Protein Biochemistry, Tarrytown, New York, USA.
  • Wang F; Merck & Co. Inc., Analytical Research & Development, Kenilworth, New Jersey, USA.
  • Gaza-Bulseco G; AbbVie Bioresearch Center, Protein Analytics, Worcester, Massachusetts, USA.
  • Hurkmans K; AbbVie Bioresearch Center, Protein Analytics, Worcester, Massachusetts, USA.
  • Zhao Y; Takeda Pharmaceuticals, Pharmaceutical science, Cambridge, Massachusetts, USA.
  • Chitikila C; Janssen R&D LLC, BioTherapeutics Development and Supply, Analytical Development, Bioassay Methods Development, Malvern, Pennsylvania, USA.
  • Clavier S; Sanofi R&D, BioAnalytics, Biologics Development, Vitry-sur-seine, France.
  • Liu S; Biogen, Analytical Development, Cambridge, Massachusetts, USA.
  • Menesale E; Biogen, Analytical Development, Cambridge, Massachusetts, USA.
  • Schonenbach NS; Pfizer, Downstream Process Development, Bioprocess R&D, Chesterfield, Missouri, USA.
  • Sharma S; Bristol Meyers Squibb, Analytical Development, New York, New York, USA.
  • Valax P; Merck KGaA, Global Healthcare Operations, Development and Launch, Biotech Process Sciences, Merck BioDevelopment, Martillac, France.
  • Waerner T; Boehringer Ingelheim Pharma, GmbH & Co. KG, Analytical Development, Biologicals, Biberach, Germany.
  • Zhang L; Bristol Meyers Squibb, Analytical Development, New York, New York, USA.
  • Connolly T; Development Group Phorum, BioPhorum, The Gridiron building, One Pancras Square, London, UK.
Biotechnol Bioeng ; 118(8): 2870-2885, 2021 08.
Article em En | MEDLINE | ID: mdl-33930190
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Indústria Farmacêutica Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Indústria Farmacêutica Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos